Cost-utility analysis of the housing and health intervention for homeless and unstably housed persons living with HIV

AIDS and Behavior
David R HoltgraveArturo Valdivia Bendixen

Abstract

We present a cost-utility analysis based on data from the Housing and Health (H&H) Study of rental assistance for homeless and unstably housed persons living with HIV in Baltimore, Chicago and Los Angeles. As-treated analyses found favorable associations of housing with HIV viral load, emergency room use, and perceived stress (an outcome that can be quantitatively linked to quality of life). We combined these outcome data with information on intervention costs to estimate the cost-per-quality-adjusted-life-year (QALY) saved. We estimate that the cost-per-QALY-saved by the HIV-related housing services is $62,493. These services compare favorably (in terms of cost-effectiveness) to other well-accepted medical and public health services.

References

Dec 1, 1983·Journal of Health and Social Behavior·S CohenR Mermelstein
Jan 1, 1996·AIDS·T D Mastro, I de Vincenzi
Feb 11, 2005·The New England Journal of Medicine·Gillian D SandersDouglas K Owens
Oct 26, 2006·Medical Care·Bruce R SchackmanKenneth A Freedberg
Jul 10, 2007·AIDS and Behavior·David R HoltgraveAngela Aidala
Aug 7, 2007·AIDS and Behavior·Richard J WolitskiKevin A Fenton
Aug 22, 2007·AIDS and Behavior·Angela A Aidala, Esther Sumartojo
Dec 7, 2007·Medical Decision Making : an International Journal of the Society for Medical Decision Making·John HornbergerEric Verhulst
Feb 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rochelle P WalenskyA David Paltiel
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A David PaltielRochelle P Walensky
Apr 2, 2009·JAMA : the Journal of the American Medical Association·Mary E LarimerG Alan Marlatt
Apr 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Todd P GilmerSusan L Ettner
Apr 18, 2009·American Journal of Public Health·David BuchananDiana Garcia
Apr 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Scott D Grosse
Jun 17, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·James D ChambersMartin J Buxton
Aug 14, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David R Holtgrave
Nov 3, 2010·Psychiatric Services : a Journal of the American Psychiatric Association·Stephen R PoulinDennis P Culhane
Jan 17, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Paul G FarnhamAngela B Hutchinson

❮ Previous
Next ❯

Citations

Jul 31, 2013·AIDS and Behavior·David R HoltgraveRobin T Kelley
Aug 7, 2007·AIDS and Behavior·Richard J WolitskiKevin A Fenton
Aug 21, 2007·AIDS and Behavior·Virginia Shubert, Nancy Bernstine
Sep 12, 2013·Journal of Behavioral Medicine·Seth C KalichmanLisa Eaton
Feb 11, 2016·The Journal of the Association of Nurses in AIDS Care : JANAC·Sarah K DobbinsJoshua Bamberger
Dec 23, 2015·American Journal of Public Health·Elizabeth A Bowen, Nadine Shaanta Murshid
Nov 13, 2015·American Journal of Public Health·Angela A AidalaSean B Rourke
Apr 10, 2014·Sexually Transmitted Infections·Glenn-Milo SantosH Fisher Raymond
Sep 21, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Paul G FarnhamStephanie L Sansom
Aug 24, 2018·Journal of Public Health·Janet IgeGabriel Scally
May 8, 2018·Infectious Diseases in Obstetrics and Gynecology·Rachel K ScottChun-Chih Huang
Aug 27, 2021·AIDS and Behavior·Laura J DunlapKenneth Silverman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.